Vascular Biology |
From the Department of Cardiovascular Medicine (T.K., H.S., K. Miyata, I.K., Y.E., K. Morishige, Y.M., A.T.) and the Department of Anesthesiology and Critical Care Medicine (T.K., S.T.), Kyushu University Graduate School of Medical Sciences, Fukuoka, Japan and the Department of Pharmacology, School of Pharmaceutical Sciences, University of Shizuoka, Shizuoka, Japan (K.O., K.N.).
Correspondence to Hiroaki Shimokawa, MD, PhD, Department of Cardiovascular Medicine, Kyushu University Graduate School of Medical Sciences, 31-1 Maidashi, Higashi-ku Fukuoka 812-8582, Japan. E-mail shimo{at}cardiol.med.kyushu-u.ac.jp
Objective We have recently demonstrated that protein kinase C (PKC) and Rho-kinase play important roles in coronary vasospasm in a porcine model. However, it remains to be examined whether there is an interaction between the two molecules to cause the spasm.
Methods and Results A segment of left porcine coronary artery was chronically treated with IL-1ßbound microbeads in vivo. Two weeks after the operation, phorbol ester caused coronary spasm in vivo and coronary hypercontractions in vitro at the IL-1ßtreated segment; both were significantly inhibited by hydroxyfasudil, a specific Rho-kinase inhibitor. Guanosine 5'-[
-thio]triphosphate (GTP
S), which activates Rho with a resultant activation of Rho-kinase, enhanced Ca2+ sensitization of permeabilized vascular smooth muscle cells, which were resistant to the blockade of PKC by calphostin C. The GTP
S-induced Ca2+ sensitization was greater in the spastic segment than in the control segment. Western blot analysis revealed that only PKC
isoform was activated during the hypercontraction.
Conclusions These results demonstrate that PKC and Rho-kinase coexist on the same intracellular signaling pathway, with PKC located upstream on Rho-kinase, and that among the PKC isoforms, only PKC
may be involved. Thus, the strategy to inhibit Rho-kinase rather than PKC may be a more specific and useful treatment for coronary spasm.
Key Words: arteriosclerosis coronary disease smooth muscle signal transduction
This article has been cited by other articles:
![]() |
S.-K. Choi, D.-S. Ahn, and Y.-H. Lee Comparison of contractile mechanisms of sphingosylphosphorylcholine and sphingosine-1-phosphate in rabbit coronary artery Cardiovasc Res, May 1, 2009; 82(2): 324 - 332. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. A. Gupte, P. M. Kaminski, S. George, L. Kouznestova, S. C. Olson, R. Mathew, T. H. Hintze, and M. S. Wolin Peroxide generation by p47phox-Src activation of Nox2 has a key role in protein kinase C-induced arterial smooth muscle contraction Am J Physiol Heart Circ Physiol, April 1, 2009; 296(4): H1048 - H1057. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Nobe, T. Yamazaki, N. Tsumita, T. Hashimoto, and K. Honda Glucose-Dependent Enhancement of Diabetic Bladder Contraction Is Associated with a Rho Kinase-Regulated Protein Kinase C Pathway J. Pharmacol. Exp. Ther., March 1, 2009; 328(3): 940 - 950. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. Patel and S. Rattan Cellular regulation of basal tone in internal anal sphincter smooth muscle by RhoA/ROCK Am J Physiol Gastrointest Liver Physiol, June 1, 2007; 292(6): G1747 - G1756. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Budzyn, M. Paull, P. D. Marley, and C. G. Sobey Segmental Differences in the Roles of Rho-Kinase and Protein Kinase C in Mediating Vasoconstriction J. Pharmacol. Exp. Ther., May 1, 2006; 317(2): 791 - 796. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. D. Roghair, J. L. Segar, R. V. Sharma, M. C. Zimmerman, D. K. Jagadeesha, E. M. Segar, T. D. Scholz, and F. S. Lamb Newborn lamb coronary artery reactivity is programmed by early gestation dexamethasone before the onset of systemic hypertension Am J Physiol Regulatory Integrative Comp Physiol, October 1, 2005; 289(4): R1169 - R1176. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Shimokawa and A. Takeshita Rho-Kinase Is an Important Therapeutic Target in Cardiovascular Medicine Arterioscler Thromb Vasc Biol, September 1, 2005; 25(9): 1767 - 1775. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Pang, Z. Guo, W. Su, Z. Xie, M. Eto, and M. C. Gong RhoA-Rho kinase pathway mediates thrombin- and U-46619-induced phosphorylation of a myosin phosphatase inhibitor, CPI-17, in vascular smooth muscle cells Am J Physiol Cell Physiol, August 1, 2005; 289(2): C352 - C360. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. E. Roberts The Role of Rho Kinase and Extracellular Regulated Kinase-Mitogen-Activated Protein Kinase in {alpha}2-Adrenoceptor-Mediated Vasoconstriction in the Porcine Palmar Lateral Vein J. Pharmacol. Exp. Ther., November 1, 2004; 311(2): 742 - 747. [Abstract] [Full Text] [PDF] |
||||
![]() |
B.R. Wamhoff, D.K. Bowles, O.G. McDonald, S. Sinha, A.P. Somlyo, A.V. Somlyo, and G.K. Owens L-type Voltage-Gated Ca2+ Channels Modulate Expression of Smooth Muscle Differentiation Marker Genes via a Rho Kinase/Myocardin/SRF-Dependent Mechanism Circ. Res., August 20, 2004; 95(4): 406 - 414. [Abstract] [Full Text] [PDF] |
||||
|
ATVB Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2003 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |